Guide to Eosinophils (Total)

WRITTEN BY
Updated: 05/22/2025|12 min read

Summary

Eosinophils are a type of white blood cell (leukocyte) that play important roles in allergic responses, fighting parasitic infections, and regulating inflammation.

Why It Matters

When activated, eosinophils release toxic granule proteins that are highly effective at killing parasites. But they can also damage your own tissues when inappropriately deployed. Eosinophils also produce signaling molecules that help coordinate various immune responses, particularly in allergic reactions.

In addition to these traditional roles, eosinophils contribute to tissue remodeling, metabolic homeostasis, and defense against certain bacterial and viral infections.

Both the absolute eosinophil count (total number per volume of blood) and relative percentage (proportion of total white blood cells) are measured as part of a complete blood count (CBC) with differential. Measuring eosinophil levels helps diagnose allergic conditions, detect parasitic infections, monitor certain autoimmune diseases, evaluate medication reactions, and assess for rare eosinophilic disorders.

The duration of eosinophil elevations provides important clinical context. Transient increases, often seen with seasonal allergies, food reactions, or medication effects, typically resolve within days to weeks once the trigger is removed. These temporary changes rarely require intervention beyond addressing the underlying cause.

In contrast, chronic elevations (persisting >6 months), particularly when counts exceed 1,500 cells/μL, may indicate serious conditions like hypereosinophilic syndrome, eosinophilic granulomatosis with polyangiitis, or certain lymphomas. Persistent elevations warrant thorough investigation because eosinophils release toxic proteins that, while effective against parasites, can damage tissues and organs over time, potentially leading to heart, lung, skin, or nervous system complications if left untreated.

Why Total and Percent Are Measured

Measuring both absolute (total) eosinophil count and the percentage provides complementary information that enables more accurate clinical interpretation:

Absolute eosinophil count (cells/μL):

  • Represents the actual number of eosinophils circulating in a defined volume of blood
  • Provides a direct quantitative measurement independent of other cell types
  • Used to diagnose conditions like hypereosinophilic syndrome, which requires counts ≥1,500 cells/μL

Eosinophil percentage (%):

  • Shows the proportion of eosinophils relative to total white blood cells
  • Helps identify relative eosinophilia (elevated percentage but normal absolute count)

These measurements lead to different clinical interpretations:

  • High absolute count with normal percentage: Indicates overall increased white blood cells with a proportional increase in eosinophils, suggesting infection or inflammation
  • Normal absolute count with a high percentage: May indicate bone marrow suppression with selective sparing of eosinophils
  • High absolute count with high percentage: True eosinophilia, pointing to allergic reaction, parasitic infection, or eosinophilic disorder
  • Low absolute count with a normal percentage: May suggests general leukopenia affecting all cell lines

Clinicians use these patterns to differentiate between primary eosinophilic disorders and secondary responses to other conditions, guiding appropriate treatment approaches.

Associated Symptoms

Eosinophil levels themselves are laboratory findings rather than medical conditions. However, abnormal levels may be associated with various health conditions, each with its own symptoms.

Common symptoms that may indicate conditions associated with elevated eosinophils (eosinophilia):

  • Itching and rashes: Skin manifestations of allergic reactions mediated by eosinophil activation
  • Respiratory symptoms: Wheezing, coughing, or shortness of breath related to airway inflammation in eosinophilic asthma (or other asthma subtypes) or other eosinophilic lung diseases
  • Nasal congestion: Stuffiness or runny nose from inflamed nasal passages in allergic rhinitis or eosinophilic chronic rhinosinusitis
  • Digestive issues: Abdominal pain, diarrhea, or blood in stool from inflammatory processes in eosinophilic gastrointestinal disorders
  • Fatigue: General tiredness resulting from chronic inflammation or the underlying condition causing eosinophilia

Decreased eosinophils (eosinopenia) generally cause no direct symptoms themselves. However, they may coincide with symptoms of conditions that cause eosinopenia, such as:

  • Stress responses: Symptoms of acute stress or infection
  • Medication effects: Side effects of drugs like corticosteroids that lower eosinophil counts

It's important to understand that many factors can cause these symptoms, and eosinophil levels are just one piece of diagnostic information. The presence of symptoms alongside abnormal eosinophil levels provides context for further investigation, but additional testing is typically needed to determine the underlying cause.

Clinical Ranges

Lab Reference Range: 15-500 cells/uL

Lifestyle Factors That Can Impact It

Factors that may increase eosinophil levels include the following:

  • Exposure to allergens such as foods, pollens, dust mites, pet dander, etc.
  • Smoking
  • Certain dietary supplements, such as vitamin D
  • Vigorous exercise in susceptible people (exercise-induced asthma)

Factors that may decrease eosinophil levels in the case of elevated counts include the following:

  • Stress management practices (yoga, meditation, etc.)
  • Smoking cessation (if previously elevated due to smoking-related inflammation)
  • Elimination diets that remove food allergens
  • Improved indoor air quality (reducing environmental allergens)
  • Vitamin D deficiency can increase eosinophils (and vitamin D treatment in asthma can help lower eosinophils).
  • Alcohol can decrease eosinophils

Other Factors That Can Impact It

Medical Conditions

  • Parasitic infections: Can elevate eosinophil counts as these cells are specifically designed to combat parasites by releasing toxic proteins
  • Autoimmune disorders (such as eosinophilic granulomatosis with polyangiitis): Cause eosinophil increases due to dysregulated immune responses
  • Certain cancers, particularly Hodgkin lymphoma: Can double or triple eosinophil counts through abnormal production of eosinophil-stimulating factors
  • Severe acute infections (sepsis): Typically decrease eosinophil counts as cells are redistributed to tissues

Medications

  • Corticosteroids: Dramatically reduce eosinophil counts within hours by preventing their release from bone marrow and causing existing cells to die off
  • Many antibiotics, particularly beta-lactams and sulfonamides: Can increase eosinophils in some people through allergic or hypersensitivity reactions
  • NSAIDs such as aspirin and ibuprofen: Can trigger eosinophil increases in sensitive people, especially those with underlying respiratory disease
  • Some heart medications such as ACE inhibitors: Occasionally cause eosinophil elevations as a side effect
  • Chemotherapy drugs: Typically decrease eosinophils by suppressing bone marrow production of all white blood cells
  • Biologic medications such as mepolizumab or benralizumab: Can reduce eosinophil counts as they're specifically designed to target pathways that produce or activate these cells

Testing Accuracy and Stability

Eosinophil testing is generally reliable. However, several factors can impact the accuracy of your results, potentially leading to values that don't truly reflect your clinical condition.

Factors That Can Affect the Accuracy of Your Test

  • Recent exercise can temporarily increase or decrease counts depending on intensity and individual response.
  • Stress during blood collection can artificially lower counts through acute cortisol release, potentially causing falsely low readings.

How it Relates to Other Markers

Eosinophil values should be interpreted alongside other blood parameters to get a more complete picture of your health stats. Other tests to consider include:

  • Total white blood cell count: This test determines whether the eosinophil percentage translates to normal or abnormal absolute counts.
  • Other white cell types: This marker helps distinguish between isolated eosinophil abnormalities and general immune responses.
  • Immunoglobulin (IgE) levels: Immunoglobulin is an antibody produced in response to an allergen. It's may beoften elevated alongside eosinophilia in allergic conditions.
  • Inflammatory markers: C-reactive protein and the erythrocyte sedimentation rate may be elevated with certain causes of eosinophilia like vasculitis.
  • Stool ova and parasite testing: You may receive these tests if your healthcare provider believes a parasitic infection is causing your eosinophilia.
  • Specific organ function tests: These tests help identify end-organ damage in hypereosinophilic conditions.

What Results May Mean in the Context of Other Markers

  • Elevated eosinophils with elevated IgE: May suggest allergic reaction; can be seen in asthma, allergic rhinitis, and atopic dermatitis.
  • Elevated eosinophils with normal IgE: May point to nonallergic causes, including parasitic infections, drug reactions, or certain autoimmune disorders.
  • Elevated eosinophils with anemia, abnormal platelets, or other abnormal white cells: May indicate bone marrow disorders or advanced hypereosinophilic syndromes; requires hematology evaluation.
  • Elevated eosinophil percentage with normal absolute count: May indicate relative eosinophilia due to decreases in other white cell populations.
  • Low eosinophils with elevated neutrophils and cortisol: May indicate a stress response pattern seen in acute infections or physiological stress.
  • Low eosinophils with low lymphocytes: May suggest corticosteroid effect, either from medications or the body's own cortisol production.

Follow-up Considerations

If your eosinophil levels are abnormal, your healthcare provider will develop a personalized approach that may include identifying triggers, adjusting medications, or treating underlying conditions. This approach typically involves monitoring through repeated testing and may require additional specialized testing to determine the specific cause and any resulting organ damage. You should always speak to your doctor if you have medical questions or before making medical decisions.

When Re-Testing May Be Appropriate

  • Mild elevations without symptoms: 3--6 months
  • After starting medications known to affect levels: 2--4 weeks
  • Moderate to severe eosinophilia: Every 1--3 months during initial workup and treatment
  • After parasite treatment: 2--4 weeks after completion
  • Known eosinophilic disorders: As directed

Additional Testing Your Doctor May Consider

  • Allergy testing (skin prick or specific IgE)
  • Chest imaging (X-ray or CT scan)
  • Pulmonary function tests
  • Specific organ biopsies when organ involvement is suspected
  • Genetic testing for certain eosinophilic disorders
  • Bone marrow examination in persistent unexplained cases
  • Specialized tests for hypereosinophilic syndrome (genetic markers, flow cytometry)

When Additional Care May Be Warranted

  • Eosinophil count >1500 cells/μL
  • Persistent unexplained eosinophilia >500 cells/μL
  • Eosinophilia with systemic symptoms (fever, weight loss, night sweats)
  • Eosinophilia with evidence of organ damage (heart, lungs, skin, nerves)
  • Rapidly rising eosinophil counts
  • New or worsening symptoms despite treatment
  • Pre-existing asthma with worsening eosinophilia

Bibliography

References

1. Khoury, Paneez, and Bruce S. Bochner. "Consultation for Elevated Blood Eosinophils: Clinical Presentations, High Value Diagnostic Tests, and Treatment Options." The Journal of Allergy and Clinical Immunology: In Practice, vol. 6, no. 5, 2018, pp. 1446--1453. https://doi.org/10.1016/j.jaip.2018.04.030. 2. Valent, Peter, et al. "Contemporary Consensus Proposal on Criteria and Classification of Eosinophilic Disorders and Related Syndromes." Journal of Allergy and Clinical Immunology, vol. 130, no. 3, 2012, pp. 607--612. https://doi.org/10.1016/j.jaci.2012.02.019. 3. Klion, Amy D. "Eosinophilia: A Pragmatic Approach to Diagnosis and Treatment." Hematology American Society of Hematology Education Program, vol. 2015, no. 1, 2015, pp. 92--97. https://doi.org/10.1182/asheducation-2015.1.92. 4. Gotlib, Jason. "World Health Organization-defined Eosinophilic Disorders: 2017 Update on Diagnosis, Risk Stratification, and Management." American Journal of Hematology, vol. 92, no. 11, 2017, pp. 1243--1259. https://doi.org/10.1002/ajh.24880. 5. Wen, Ting, and Marc E. Rothenberg. "The Regulatory Function of Eosinophils." Microbiology Spectrum, vol. 4, no. 5, 2016. https://doi.org/10.1128/microbiolspec.MCHD-0020-2015. 6. Radonjic-Hoesli, Susanne et al. "Eosinophils in skin diseases." Seminars in immunopathology vol. 43,3 (2021): 393-409. doi:10.1007/s00281-021-00868-7 7. Abidi, K., Khoudri, I., Belayachi, J. et al. Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units. Crit Care 12, R59 (2008). https://doi.org/10.1186/cc6883 8. Lee, Younghak et al. "The Eosinophil Count Tends to Be Negatively Associated with Levels of Serum Glucose in Patients with Adrenal Cushing Syndrome." Endocrinology and Metabolism (Seoul, Korea) vol. 32,3 (2017): 353-359. doi:10.3803/EnM.2017.32.3.353 9. de Groot, Jantina C., et al. "Vitamin D Reduces Eosinophilic Airway Inflammation in Nonatopic Asthma." Journal of Allergy and Clinical Immunology, vol. 135, no. 3, 2015, pp. 670--675.e3. 10. Hernández-Colín, Dante Daniel et al. "Serum Vitamin D Is Inversely Associated with Blood Eosinophil Count Among Adults with Allergic Asthma." Thoracic Research and Practice, vol. 24,4 (2023): 208-213. doi:10.5152/ThoracResPract.2023.22154 11. Payne, Spencer C., et al. "Activation of Basophils and Eosinophils by EtOH in Alcohol Sensitive Patients with CRS and Asthma." Journal of Allergy and Clinical Immunology, vol. 139, no. 2, 2017, p. AB90. 12. Hussain, Musaddique, and Gang Liu. "Eosinophilic Asthma: Pathophysiology and Therapeutic Horizons." Cells vol. 13,5 384. 23 Feb. 2024, doi:10.3390/cells13050384

Sign up for the Levels Newsletter